玻璃體腔注射Bevacizumab治療黃種人脈絡膜新生血管的臨床療效觀察.pdf

1、山東大學碩士學位論文玻璃體腔注射Bevacizumab治療黃種人脈絡膜新生血管的臨床療效觀察姓名：潘雪梅申請學位級別：碩士專業(yè)：眼科學指導教師：周芳20090515山東大學碩上學位論文IntravitrevousinjectionwithBevacizumabforchoroidalneovascularizationofyellowraceGraduatestudent：PanXueMeiTutor：ProfessorZhouFang

2、ABSTRACT[Purpose]Toobserveandevaluatetheefficacyandsafetyofintravitreousinjection、)l，itllBevacizumabforchoroidalneovascularizationofyellowrace【Method】Clinicaldiagnosisofthedifferentcausesofchoroidalneovascularization(CNV

3、)caused92eyesof88CaSeSwhohadintravitrealinjectionofBevacizumabIncluding43eyesof41casesinagerelateddegeneration(AMD)，therewerepredominantlyclassicCNVin12eyes，minimallyclassicCNVin6eyeandoccultCNVin12eyeof43eyesinAMD14eyes

4、of13casesinpathologicmyopia(PM)，26eyesof26casesinidiopathicchoroidalneovascularization，7eyesof7e41sesinpolypoidalchoroidalvasculopathy口Cv)，2eyesofonecaseinangioidstreaksRegularfollowupTheexaminationthebestcorrectedvisual

5、acuityocularfundusfluoresceinangiography(FFA)andindocyaninegreenangiography(ICGA)andopticalcoherencetomography(OCT)weredone，followupperiodTherelapsehadthesamewayfortreatmentduringfollowupperiod，thechangesofthembeforeanda

6、fterthetreatmentwereobservedandcomparedTocomparethechangesofbestcorrectedvisualacuityfundusmanifestations，fundusfluresceinangiography(FFA)andindocyaninegreenangiography(ICGA)，opticalcoherencetomography(OCT)beforeandafter

7、intravitreousinjectionwimBevacizumab[Result]Followuptimevariedfrom3monthto19months，mean117months36eyesweretreatedonce，44eyesreceivedretreatmentstwice，12eyesweretreatedthreetimes硼1efinalbestcorrectedvisualacuityimprovedin